CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 13, 2026

Total Value ($000): $4,279 (100.0% shares, 0.0% debt)

Holdings (11)

New Positions (2)

SYRE SPYRE THERAPEUTICS INC 6.8%

Value ($000) $292 Shares 8,919 Est. Cost $26.13 Unrealized 0.0%

XFOR X4 PHARMACEUTICALS INC 1.5%

Value ($000) $62 Shares 15,557 Est. Cost $3.63 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SYRE	SPYRE THERAPEUTICS INC	8,919	$292	6.8%	$26.13	0.0%	COM NEW	00773J202
XFOR	X4 PHARMACEUTICALS INC	15,557	$62	1.5%	$3.63	0.0%	COM NEW	98420X202

Increased Positions (2)

IKT INHIBIKASE THERAPEUTICS INC 1.4%

Value ($000) $58 (+119.6%) Shares 28,453 (+73.6%) Est. Cost $2.11 Unrealized -24.6%

BRK/B BERKSHIRE HATHAWAY INC DEL 8.3%

Value ($000) $357 (+9.0%) Shares 710 (+9.1%) Est. Cost $409.76 Unrealized +21.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IKT	INHIBIKASE THERAPEUTICS INC	28,453 (+73.6%)	$58 (+119.6%)	1.4%	$2.11	-24.6%	COM NEW	45719W205
BRK/B	BERKSHIRE HATHAWAY INC DEL	710 (+9.1%)	$357 (+9.0%)	8.3%	$409.76	+21.4%	CL B NEW	084670702

Exited Positions (3)

RZLT REZOLUTE INC 436.4%

Value ($000) $18,676 Shares 1,986,818 Est. Cost $8.14 Unrealized -3.6%

ELVN ENLIVEN THERAPEUTICS INC 6.3%

Value ($000) $268 Shares 13,097 Est. Cost $18.93 Unrealized +5.2%

BCAX BICARA THERAPEUTICS INC 4.0%

Value ($000) $173 Shares 10,941 Est. Cost $25.50 Unrealized -33.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RZLT	REZOLUTE INC	1,986,818	$18,676	436.4%	$8.14	-3.6%	—	76200L309
ELVN	ENLIVEN THERAPEUTICS INC	13,097	$268	6.3%	$18.93	+5.2%	—	29337E102
BCAX	BICARA THERAPEUTICS INC	10,941	$173	4.0%	$25.50	-33.0%	—	055477103

Decreased Positions (6)

GLD SPDR GOLD TR 64.5%

Value ($000) $2,760 (+6.6%) Shares 6,964 (-4.4%) Est. Cost $310.70 Unrealized —

— MIND MEDICINE MINDMED INC 4.9%

Value ($000) $210 (-34.0%) Shares 15,688 (-41.9%) Est. Cost $8.91 Unrealized —

KYTX KYVERNA THERAPEUTICS INC 4.1%

Value ($000) $176 (+28.0%) Shares 18,773 (-18.3%) Est. Cost $23.94 Unrealized -69.0%

CMPX COMPASS THERAPEUTICS INC 3.7%

Value ($000) $158 (-15.4%) Shares 29,495 (-44.9%) Est. Cost $3.22 Unrealized +43.5%

LXEO LEXEO THERAPEUTICS INC 3.2%

Value ($000) $138 (+20.3%) Shares 13,943 (-19.6%) Est. Cost $13.31 Unrealized -31.4%

SABS SAB BIOTHERAPEUTICS INC 0.9%

Value ($000) $39 (+79.1%) Shares 10,527 (-3.7%) Est. Cost $2.26 Unrealized +45.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GLD	SPDR GOLD TR	6,964 (-4.4%)	$2,760 (+6.6%)	64.5%	$310.70	—	GOLD SHS	78463V107
—	MIND MEDICINE MINDMED INC	15,688 (-41.9%)	$210 (-34.0%)	4.9%	$8.91	—	COM NEW	60255C885
KYTX	KYVERNA THERAPEUTICS INC	18,773 (-18.3%)	$176 (+28.0%)	4.1%	$23.94	-69.0%	COM	501976104
CMPX	COMPASS THERAPEUTICS INC	29,495 (-44.9%)	$158 (-15.4%)	3.7%	$3.22	+43.5%	COM	20454B104
LXEO	LEXEO THERAPEUTICS INC	13,943 (-19.6%)	$138 (+20.3%)	3.2%	$13.31	-31.4%	COM	52886X107
SABS	SAB BIOTHERAPEUTICS INC	10,527 (-3.7%)	$39 (+79.1%)	0.9%	$2.26	+45.5%	COM NEW	78397T202

Unchanged Positions (1)

CNTX CONTEXT THERAPEUTICS INC 0.6%

Value ($000) $27 Shares 18,403 Est. Cost $1.72 Unrealized -32.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTX	CONTEXT THERAPEUTICS INC	18,403	$27	0.6%	$1.72	-32.2%	COM	21077P108